PuSH - Publication Server of Helmholtz Zentrum München

45 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Cirac, A. et al.: Epstein-Barr virus strain heterogeneity impairs human T-cell immunity. Cancer Immunol. Immunother. 67, 663-674 (2018)
2.
Gary, R.* et al.: Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. J. Transl. Med. 16:124 (2018)
3.
Huth, A. ; Liang, X. ; Krebs, S.* ; Blum, H.* & Moosmann, A.: Antigen-specific TCR signatures of cytomegalovirus infection. J. Immunol. 202, 979-990 (2018)
4.
Schlott, F.* et al.: Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells. PLoS ONE 13:e0193554 (2018)
5.
Gary, R.* et al.: Adoptive transfer of CMV- and EBV-specific peptide-stimulated T cells after allogeneic stem cell transplantation: First results of a phase I/IIa clinical trial [AIT-MULTIVIR-01]. Oncol. Res. Treat. 40, 239-239 (2017)
6.
Lichtenegger, F.S. et al.: Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: Results of a phase I/II trial and ex vivo enhancement by checkpoint blockade. Oncol. Res. Treat. 40, 135-135 (2017)
7.
Link, E.K.* et al.: A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells. Vaccine 35, 5131-5139 (2017)
8.
Albanese, M. et al.: Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc. Natl. Acad. Sci. U.S.A. 113, E6467-E6475 (2016)
9.
Hubmann, M.* et al.: Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation. J. Clin. Virol. 82, 33-40 (2016)
10.
Lichtenedger, F.S. et al.: Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: results of a phase I/II trial and ex vivo enhancement by checkpoint blockade. Oncol. Res. Treat. 39, 135-135 (2016)
11.
Lichtenegger, F.S. et al.: Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial. Cancer Immunol. Res. 4:B146 (2016)
12.
Tagawa, T. et al.: Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J. Exp. Med. 213, 2065-2080 (2016)
13.
Ameres, S. ; Liang, X. ; Wiesner, M. ; Mautner, J. & Moosmann, A.: A diverse repertoire of CD4 T cells targets the immediate-early 1 protein of human cytomegalovirus. Front. Immunol. 6:598 (2015)
14.
Deiser, K. et al.: Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial. Blood 126:3805 (2015)
15.
Lichtenegger, F.S. et al.: Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial. Oncol. Res. Treat. 38, 37 (2015)
16.
Rancan, C. ; Schirrmann, L. ; Hüls, C. ; Zeidler, R. & Moosmann, A.: Latent membrane protein LMP2A impairs recognition of EBV-infected cells by CD8+ T cells. PLoS Pathog. 11:e1004906 (2015)
17.
Ritter, I.* et al.: T-cell receptor deep sequencing analysis of EBV specific T cells before and after adoptive transfer in a patient after allogeneic stem cell transplantation. Bone Marrow Transplant. 50, S400 (2015)
18.
Schnorfeil, F.M. et al.: Dendritic cell vaccination in postremission therapy of aml: Results of a clinical phase i trial and of preclinical studies testing combinatorial approaches. Haematologica 100, 287 (2015)
19.
Tischer, J.* et al.: Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: Incidence in the context of immune recovery in two different transplantation settings. Ann. Hematol. 94, 1677-1688 (2015)
20.
Ameres, S. ; Besold, K.* ; Plachter, B.* & Moosmann, A.: CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity. J. Immunol. 192, 5894-5905 (2014)